Skip to main content
. 2020 Jul 6;15(2):232–242. doi: 10.5009/gnl19433

Fig. 1.

Fig. 1

Flowchart of study cohort enrollment and identification of ulcerative colitis (UC) in biologic-naïve patients treated with tumor necrosis factor-α (TNF-α) inhibitors infliximab or adalimumab.